EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RBM10 Deficiency Promotes Anti‐PD‐1 Resistance in LUAD via STING Alternative Splicing‐Driven CCL7 Signaling and Macrophage Polarization

Weitong Gao, Ruqiong Wang, Bo An, Lishuang Qi, Zihan Jing, Xingmei Ren, Yang Zhou, Mingjun Xu, Jiaojiao Li, Jie Liu, Liying Wang, Gang Xu und 3 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202522159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Weitong Gao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Lung Neoplasms, Immune Checkpoint Inhibitors, Adenocarcinoma of Lung. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although immune checkpoint inhibitors have improved outcomes in lung adenocarcinoma (LUAD), many patients still exhibit inadequate responses. The immunomodulatory functions of RNA‐binding motif (RBM) proteins remain poorly understood. Using in vivo and in vitro models of RBM10 deficiency combined with cytokine arrays, CLIP‐seq, RIP, and proteomics, we found that RBM10 deficiency promotes an immunosuppressive microenvironment, and targeting key chemokines restored anti‐PD‐1 efficacy in RBM10‐deficient LUAD models. RBM10 deficiency enhanced the polarization and recruitment of M2 tumor‐associated macrophages (TAMs), both in vitro and in vivo. Mechanistically, RBM10 loss disrupted STING exon 3 exclusion via alternative splicing and impaired QKI‐mediated stabilization of the STING‐E3(‐) isoform, shifting the splicing balance toward the STING‐E3(+) isoform and promoting CCL7 secretion. CCL7 acted through its receptor CCR2 on macrophages, driving M2 polarization and recruitment. This central pathway was further reinforced by a positive feedback loop wherein M2‐polarized TAMs transferred mitochondria to tumor cells, potentially contributing to mtDNA‐cGAS‐STING signaling and sustained CCL7 production. Therapeutically, CCL7/CCR2 blockade synergized with PD‐1 inhibition to promote tumor regression in RBM10‐deficient tumors. Collectively, RBM10 serves as a key immunoregulator in LUAD by modulating the STING‐CCL7‐CCR2 axis, and targeting the CCL7‐CCR2 axis represents a promising strategy to overcome anti‐PD‐1 resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsLung NeoplasmsImmune Checkpoint InhibitorsAdenocarcinoma of LungMembrane ProteinsMacrophagesProgrammed Cell Death 1 ReceptorAnimalsAlternative SplicingHumansMiceSignal TransductionSTING ProteincGAS-STING Signaling PathwayTumor-Associated MacrophagesTumor MicroenvironmentDrug Resistance, Neoplasm

Stichwörter der Autor:innen

RNA‐binding motif 10alternative splicingimmune checkpoint inhibitorsmitochondrial transfertumor‐associated macrophages

Substanzen

RNA-Binding ProteinsImmune Checkpoint InhibitorsMembrane ProteinsProgrammed Cell Death 1 ReceptorSTING ProteinSTING1 protein, human

Autor:innen und Institutionen

  • Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
  • College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Department of Radiation Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Department of Oncology, Chaoyang Central Hospital of China Medical University, Chaoyang, Liaoning Province, China.
  • Department of Respiratory and Critical Care Medicine, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing, China.
  • China-Japan Friendship Hospital (Institute of Clinical Medical Sciences, Beijing, China.

ORCID-Profile: Dexin Jia, Yan Yu

Zitieren

APA

Gao, W., Wang, R., An, B., Qi, L., Jing, Z., Ren, X., Zhou, Y., Xu, M., Li, J., Liu, J., Wang, L., Xu, G., Li, R., Jia, D., & Yu, Y. (2026). RBM10 Deficiency Promotes Anti‐PD‐1 Resistance in LUAD via STING Alternative Splicing‐Driven CCL7 Signaling and Macrophage Polarization. Advanced Science. https://doi.org/10.1002/advs.202522159

Vancouver

Gao W, Wang R, An B, Qi L, Jing Z, Ren X, et al. RBM10 Deficiency Promotes Anti‐PD‐1 Resistance in LUAD via STING Alternative Splicing‐Driven CCL7 Signaling and Macrophage Polarization. Advanced Science. 2026. doi:10.1002/advs.202522159

BibTeX
@article{Gao2026,
  author = {Gao, Weitong and Wang, Ruqiong and An, Bo and Qi, Lishuang and Jing, Zihan and Ren, Xingmei and Zhou, Yang and Xu, Mingjun and Li, Jiaojiao and Liu, Jie and Wang, Liying and Xu, Gang and Li, Rou and Jia, Dexin and Yu, Yan},
  title = {RBM10 Deficiency Promotes Anti‐PD‐1 Resistance in LUAD via STING Alternative Splicing‐Driven CCL7 Signaling and Macrophage Polarization},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202522159}
}
Kostenlos starten →